Factor XI inhibitor–based anticoagulation strategies gain ground
November 18, 2020
“When we compare the FXI inhibitors with existing anticoagulants, we don’t necessarily want to go up against the DOACs.”
COVID-19 diagnosed on CTA scan in stroke patients
October 29, 2020
“As part of the stroke evaluation workup process, we were able to diagnose COVID-19 at the same time at no extra cost or additional workload.”
‘Cautious’ DOAC underdosing in AFib may push mortality higher
September 21, 2020
Risk-averse clinicians might be doing more harm than good by prescribing direct oral anticoagulants at lower-than-recommended dosages in hope of avoiding bleeding complications, suggests a study.
Many providers don’t follow hypertension guidelines
September 17, 2020
Most health care professionals rely on clinic BP measurements to make a new diagnosis of hypertension, and view pressure measured manually with a cuff and stethoscope as accurate.
The earlier the better for colchicine post-MI: COLCOT
September 14, 2020
One substudy supported in-hospital initiation of colchicine and a second offered clues as to who may respond or experience tell-tale GI events.
Minidose edoxaban may safely cut AFib stroke risk in the frail, very elderly
September 3, 2020
Those who took the factor Xa inhibitor edoxaban (Savaysa) at the off-label dosage of 15 mg once daily showed a two-thirds drop in risk for stroke or systemic embolism, compared with patients who received placebo.
Hypertension often goes undertreated in patients with a history of stroke
August 10, 2020
Uncontrolled hypertension is common, even among those who have survived a stroke.
COVID-19 fears would keep most Hispanics with stroke, MI symptoms home
July 27, 2020
Survey: Hispanics are significantly more likely than Blacks or Whites to be afraid to go to the hospital for a heart attack or stroke.
New oral anticoagulants drive ACC consensus on bleeding
July 22, 2020
A new consensus document from the American College of Cardiology updates management of acute bleeding in patients on oral anticoagulants.
Ticagrelor/aspirin combo: Fewer repeat strokes and deaths, but more bleeds
July 22, 2020
The combination also increased the risk for major hemorrhage, but that increase was small and would not overwhelm the benefit.